Similar articles

• Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.

  Friedel HA, Brogden RN. Friedel HA, et al. Drugs. 1990 Jun;39(6):929-67. doi: 10.2165/00003495-199039060-00008. Drugs. 1990. PMID: 2196168 Review.
• Pinacidil: potassium channel openers in the treatment of hypertension. Proceedings of a symposium. Copenhagen, 10-11 March, 1988.

  [No authors listed] [No authors listed] Drugs. 1988;36 Suppl 7:1-98. Drugs. 1988. PMID: 3254829 No abstract available.
• Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.

  Atwal KS. Atwal KS. J Cardiovasc Pharmacol. 1994;24 Suppl 4:S12-7. J Cardiovasc Pharmacol. 1994. PMID: 7898103 Review.
• [Potassium channel openers. A new possible therapeutic principle in several diseases].

  Drottning P, Christensen H, Storstein L. Drottning P, et al. Tidsskr Nor Laegeforen. 1994 Feb 10;114(4):450-3. Tidsskr Nor Laegeforen. 1994. PMID: 8009483 Norwegian.
• Clinical pharmacology of pinacidil, a prototype for drugs that affect potassium channels.

  Goldberg MR. Goldberg MR. J Cardiovasc Pharmacol. 1988;12 Suppl 2:S41-7. doi: 10.1097/00005344-198812002-00008. J Cardiovasc Pharmacol. 1988. PMID: 2466178 Review.